Vaccinations for Hepatitis A and B
Candidates for Hepatitis A Vaccination
Routine Vaccination
- Children living in areas with high incidence rates of hepatitis A.
- High-Risk Populations
- Travelers to developing countries with high rates of hepatitis A, including Mexico
- Men who have sex with men
- Users of illegal drugs
- People who work with hepatitis A virus in research settings
- People who work with infected nonhuman primates
- Recipients of clotting factor concentrates
- People with chronic liver disease (because of risk of fulminant hepatitis A)
Candidates for Hepatitis B Vaccination
- All infants, children, and adolescents
- High-Risk Populations
- People with multiple sex partners and those who have been recently diagnosed with a sexually transmitted disease
- Sex partners and household contacts of HBV carriers
- Men who have sex with men
- Household contacts of adoptees from countries with high rates of hepatitis B
- Injection drug users
- Travelers to countries with high rates of hepatitis B (staying longer than 6 months)
- People with occupational exposure to blood
- Clients and staff in institutions for the developmentally disabled
- Patients with chronic kidney failure (including those on chronic hemodialysis)
- Patients receiving clotting factor concentrates
- Inmates of long-term correctional facilities
Postexposure Prophylaxis
Prophylactic treatment for exposure to hepatitis B virus involves either hepatitis B immune globulin (HBIG), hepatitis B vaccine, or a combination of both. The HBIG dose equals 0.06 mL/kg. Efficacy ranges from 70 to 95 percent for different types of exposure.
Exposure | Treatment |
Perinatal | 1 dose of HBIG given with the first hepatitis B vaccine dose. |
Percutaneous or permucosal | HBIG and vaccination depending on vaccination and exposure status. |
Sexual | HBIG with or without vaccination for exposure to acute hepatitis B; vaccination alone for chronic exposure. |
Household contact | HBIG with vaccination for acute hepatitis B in infants under age 12 months; vaccination alone for chronic. |
Combination Vaccine
There are combination vaccines available that combine vaccinations for hepatitis A and B Los Angeles in one injection. It protects individuals 18 years of age or older against diseases caused by hepatitis A and hepatitis B viruses. The vaccine is recommended for travelers whose occupation or behavior puts them at high risk for exposure to hepatitis B virus, or who are visiting countries with a high or intermediate rate of both hepatitis viruses, as defined by the Centers for Disease Control and Prevention.
Today, gastroenterology conditions can be treated effectively. We provide everyone a personalized gastroenterology treatment plan to meet your unique needs and improve your quality of life. Contact our gastroenterology and hepatology center to schedule a consolation with Los Angeles' preferred Gastroenterologist– Dr. Tabib.
Dr. Tabib's completed his postgraduate fellowship, residency, and internships at the UCLA/Cedar-Sinai Medical Center.
Get your
Consultation Today!
Siamak Tabib, M.D., Inc.
8631 W 3rd St Suite 1015E,
Los Angeles, CA 90048
(310) 652-4472
(310) 358-2266 (Fax)